Comparison of the effects of liraglutide and radio frequency cavitaion on abdominal obesityof the effects of liraglutide and radio frequency cavitaion on abdominal obesity

A Randomized Clinical Trial Comparing the Efficacy of Liraglutide and Radiofrequency Cavitation in the Management of Abdominal Obesity

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251003067486N1

Enrollment

Registered

2025-11-01

Start date

2025-11-06

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity. Obesity, unspecified

Interventions

Intervention 1: Intervention group: radiofrequency cavitation. Intervention 2: Control group: liraglutide.

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: obesity

Exclusion criteria

Exclusion criteria: Pregnancy Drug abuse Obesity due to specific endocrine disorders Alcohol use Specific diseasesuch as cancer

Design outcomes

Primary

Measure	Time frame
Waist measurement. Timepoint: three months. Method of measurement: with aa measuring tape.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactalireza aref zade

Islamic Azad University

Alireza.arefzadeh@iautmu.ac.ir+98 21 4486 7262

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026